Evidence map›Paper›PMID 42733055›Full record

ArticleNature communications2026

Weakly supervised artificial intelligence for multi-cancer detection of lymph node metastasis on whole slide images.

Lili Sun, Shuilian Yao, Qi Jia, Yanmei Zhu

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lili Sun *Department of Pathology, Cancer Hospital of Dalian University of Technology (Liaoning Cancer Hospital and Institute, Cancer Hospital of China Medical University), Shenyang, China.ORCID http://orcid.org/0000-0002-2656-693X
Shuilian Yao *School of Software Technology, DUT-RU International School of Information Science & Engineering, Dalian University of Technology, Dalian, China.ORCID http://orcid.org/0009-0005-8196-8033
Qi JiaSchool of Software Technology, DUT-RU International School of Information Science & Engineering, Dalian University of Technology, Dalian, China. jiaqi@dlut.edu.cn.ORCID http://orcid.org/0000-0001-5383-0065
Yanmei ZhuDepartment of Pathology, Cancer Hospital of Dalian University of Technology (Liaoning Cancer Hospital and Institute, Cancer Hospital of China Medical University), Shenyang, China. zhuyanmei@cancerhosp-ln-cmu.com.ORCID http://orcid.org/0000-0001-5526-7624

Funding

National Natural Science Foundation of China (National Science Foundation of China) Grant 62272083National Natural Science Foundation of China (National Science Foundation of China) Grant 62495083National Natural Science Foundation of China (National Science Foundation of China) Grant 62495085Natural Science Foundation of Liaoning Province (Liaoning Provincial Natural Science Foundation) Grant 2024-MS-271Natural Science Foundation of Liaoning Province (Liaoning Provincial Natural Science Foundation) Grant 2025-MS-336
6 · The paper itself

Abstract

The accurate identification of lymph node metastasis is critical for cancer diagnosis/treatment but remains time-consuming and error-prone for pathologists. We develop MambaMIL+HiLA-MIL, a multiple instance learning model combining Vision Mamba with high-low attention separation mechanism. This model is compared against six baselines under four feature extractors (ResNet, UNI, Virchow, and GigaPath). Ten-fold cross-validation is employed for model evaluation. Our model significantly outperforms all baselines. It exhibits strong performance in detection of isolated tumor cells and micro-metastasis, while maintaining high performance for negative and macro-metastasis cases. The model still demonstrates good stability in detecting lymph node metastasis across multi-cancer and various individual cancer types. UNI and GigaPath yield significantly better performance than ResNet and Virchow. Here, we show that MambaMIL+HiLA-MIL is a multi-cancer four-class lymph node metastasis model, demonstrating high efficiency and robustness across multiple centers and various feature extractors, offering a reliable tool for clinical lymph node metastasis classification.

Indexed as

Artificial IntelligenceLymphatic MetastasisLymph NodesNeoplasmsSupervised Machine LearningConvolutional Neural NetworksHumansMultiple-Instance Learning Algorithms

Identifiers

PMID42733055
PMCPMC13572452

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.